YKL-40 – A NEW DIAGNOSTIC BIOMARCER FOR BENIGN BREAST DISEASES AND BREAST CANCER

Benign breast diseases encompass a wide spectrum of lesions, which raise a lot of questions about their classification, diagnosis, prognosis and surgical treatment. The aim of this study is to measure the serum level of YKL-40 in cases of different groups of benign breast diseases, to compare it to...

Full description

Bibliographic Details
Main Authors: Vanya Uzunova, G. Paskalev, Maria Kazakova, E. Poryazova, K. Murdjev, A. Uchikov, A. Iankulov, Victoria Sarafian, D. Manolova, A. Paskaleva, B. Hadjiev, J. Grudeva-Popova
Format: Article
Language:English
Published: Peytchinski Publishing 2010-07-01
Series:Journal of IMAB
Subjects:
Online Access:http://www.journal-imab-bg.org/statii-10/vol16_b3_p8-10.pdf